CA2117480A1 - Immunoglobuline humaine pour la prevention et le traitement des infections a staphylocoques - Google Patents

Immunoglobuline humaine pour la prevention et le traitement des infections a staphylocoques

Info

Publication number
CA2117480A1
CA2117480A1 CA002117480A CA2117480A CA2117480A1 CA 2117480 A1 CA2117480 A1 CA 2117480A1 CA 002117480 A CA002117480 A CA 002117480A CA 2117480 A CA2117480 A CA 2117480A CA 2117480 A1 CA2117480 A1 CA 2117480A1
Authority
CA
Canada
Prior art keywords
epidermidis
immune globulin
human immune
directed
screened
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002117480A
Other languages
English (en)
Inventor
Gerald W. Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2117480A1 publication Critical patent/CA2117480A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002117480A 1992-02-25 1992-11-09 Immunoglobuline humaine pour la prevention et le traitement des infections a staphylocoques Abandoned CA2117480A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80431792A 1992-02-25 1992-02-25
US804,317 1992-02-25

Publications (1)

Publication Number Publication Date
CA2117480A1 true CA2117480A1 (fr) 1993-09-02

Family

ID=25188685

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002117480A Abandoned CA2117480A1 (fr) 1992-02-25 1992-11-09 Immunoglobuline humaine pour la prevention et le traitement des infections a staphylocoques

Country Status (5)

Country Link
EP (1) EP0628056A4 (fr)
JP (1) JPH08504167A (fr)
AU (1) AU673508B2 (fr)
CA (1) CA2117480A1 (fr)
WO (1) WO1993017044A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4124816B2 (ja) * 1992-03-19 2008-07-23 ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン 通常のスタフィロコーカス抗原と反応する広い反応性のオプソニン抗体
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
JPH0840932A (ja) 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
KR20050099536A (ko) 2003-02-06 2005-10-13 트리펩 아베 글리코실화된 특이성 교환체
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
US20090214584A1 (en) * 2005-05-31 2009-08-27 Biostapro Ab Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis
EA016268B1 (ru) * 2009-05-12 2012-03-30 Государственное Учреждение ''Республиканский Научно-Практический Центр Трансфузиологии И Медицинских Биотехнологий'' Способ получения антистафилококковой плазмы крови
FR2989589A1 (fr) * 2012-04-20 2013-10-25 Univ Paris Curie Prevention et traitement des infections non virales chez des individus traites par des immunosuppresseurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499035A (en) * 1975-04-10 1978-01-25 Ts Nii Gematologii I Perelivan Antistaphylococcus human immune globulin and method of preparing same
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus

Also Published As

Publication number Publication date
JPH08504167A (ja) 1996-05-07
AU673508B2 (en) 1996-11-14
EP0628056A1 (fr) 1994-12-14
AU3271893A (en) 1993-09-13
WO1993017044A1 (fr) 1993-09-02
EP0628056A4 (fr) 1997-03-05

Similar Documents

Publication Publication Date Title
US6632432B1 (en) Directed human immune globulin for the prevention and treatment of staphylococcal infections
JP4656728B2 (ja) ブドウ球菌抗原及びワクチン
US5571511A (en) Broadly reactive opsonic antibodies that react with common staphylococcal antigens
US6294177B1 (en) Staphylococcus aureus antigen-containing whole cell vaccine
EP0648127B1 (fr) Antigenes de surface du type i associes au staphylococcus epidermidis
Hellman et al. Release of Gram-Negative Outer-Membrane Proteins into Human Serum and Septic Rat Blood and Their Interactions with Iminunoglobulin in Antiserum to Eschevichia coli J5
EP0694309A2 (fr) Compositions vaccinales contenant des antigènes et des anticorps pour la prévention et l'inhibition d'infections induites par les staphylocoques
CA2132421C (fr) Anticorps opsoniques largement reactifs qui reagissent avec les antigenes des staphylocoques communs
Magnadóttir et al. A comparison of total and specific immunoglobulin levels in healthy Atlantic salmon (Salmo salar L.) and in salmon naturally infected with Aeromonas salmonicida subsp. achromogenes
AT397803B (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
AU673508B2 (en) Directed human immune globulin for the prevention and treatment of staphylococcal infections
US4965068A (en) Polyvalent hyperimmunoglobulin preparation
CA2257826A1 (fr) Adhesine d'helicobacter pylori se fixant a un antigene de groupe sanguin
US5034515A (en) Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
Loeffler et al. Use of 51Cr release to measure the cytotoxic effects of staphylococcal leukocidin and toxin neutralization on bovine leukocytes
US5089262A (en) E87ag antigens of pseudomonas aeruginosa and monoclonal antibodies against them and hybridomas thereof
Dolby et al. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis
EP0761819A1 (fr) Exopolysaccharides du burkholderia pseudomallei et burkholderia mallei
CA2200691C (fr) Anticorps a activite opsonique etendue reagissant avec les antigenes du staphylocoque
AT395591B (de) Humaner monoklonaler antikoerper, verfahren zu dessen herstellung, arzneimittel und hybridzelle
Stinson et al. Binding of Streptococcus mutans antigens to heart and kidney basement membranes
Wells et al. Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria
WO1996009321A9 (fr) Anticorps a activite opsonique etendue reagissant avec les antigenes du staphylocoque
RU2311197C1 (ru) Способ получения протективной белоксодержащей фракции бактерий
Okada et al. Possible role for a polysaccharide antigen shared between Streptococcus pyogenes and S. mutans in the pathogenesis of poststreptococcal glomerulonephritis

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued